US › Healthcare

Talkspace Inc (TALK)

US · Healthcare · Health Information Services

$5.15-1.15%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$61.7M
Revenue YoY
+18.2%
Net profit
$-6.3M
Profit YoY
-2083.0%
EPS
$0.02
EPS estimate
$0.02
Net margin
-10.2%

EPS came in at 0.02 against a street estimate of 0.02 — a beat of 0.0%.

Key statistics

Market cap
$872.7M
P/E
0.0
Forward P/E
43.3
P/B
7.73
Book value
$0.68
EPS (TTM)
$0.00
52-week high
$5.25
52-week low
$2.27
50-day MA
$5.21
200-day MA
$4.42
Beta
1.12

Analyst view

Analysts rate Talkspace Inc a strong buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $6.15.

Shareholding

Insiders
5.12%
Institutions
82.95%

Largest institutional holders

FundStake
Hudson Executive Capital LP6.77%
BlackRock Inc6.21%
Balyasny Asset Management LLC5.29%
Deutsche Bank AG4.25%
Fidelity International Ltd3.99%
Vanguard Capital Management, LLC3.22%
Magnetar Financial LLC2.54%
AllianceBernstein L.P.2.30%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Talkspace Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.